6886:HKEXHuatai Securities Co., Ltd. Class H Analysis
Data as of 2026-06-21 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Anhui Wanyi Science and Technology is trading at CNY 30.4, comfortably above its 20‑day (27.02), 50‑day (27.47) and 200‑day (25.20) simple moving averages, indicating a strong upward bias. The RSI of 66.6 and a bullish MACD histogram (+0.39) suggest momentum is still positive, though the RSI hints at a potential overbought condition. Valuation metrics are stretched: the trailing P/E of 52.4 far exceeds the industry average of 38.1, and the DCF‑derived fair value of just CNY 4.30 implies a massive discount to the current price. Revenue is expanding rapidly at 33.5% year‑over‑year, supported by a solid gross margin of 47% and a modest operating margin of 7.7%, while cash balances (CNY 244 m) dwarf total debt (CNY 48 m), making the dividend of 0.66% sustainable. Volatility is high at 51.6% over the past 30 days, yet beta remains low at 0.30, indicating limited systematic risk. Analyst consensus is thin, with a single target price of CNY 29.63, slightly below market, and the Fear & Greed Index at 91.5 (Extreme Greed), signaling potential complacency among investors.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near resistance at CNY 31.76
- RSI indicating possible overbought
- Bullish MACD supporting short‑term momentum
Medium Term
1–3 yearsKey Factors
- Significant valuation gap (P/E 52.4 vs industry 38.1)
- DCF fair value far below market price
- Analyst target price below current level
Long Term
> 3 yearsKey Factors
- Strong revenue growth and cash generation
- Sustainable dividend with low payout ratio
- Low systematic risk (beta 0.30) despite high volatility
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.